Is Selank Legal in Europe? The Honest Answer Is “Legal for What?”

Type “is Selank legal in Europe” into a search bar and you will get a confident yes, a confident no, and a Russian registration certificate waved around as if it settled the matter. None of them answer the question, because the question is malformed. Legality is never a property of a molecule in the abstract; it is a property of what you intend to do with it. Selank — a Russian neuropeptide registered as a drug in Moscow but unknown to every Western regulator — is a clean case study in how that distinction gets lost.

Has any regulator actually approved Selank in Europe?

No. Selank has not been reviewed or approved as a medicine by the European Medicines Agency (EMA) or by any individual EU member state.¹ That single fact does most of the work here. The EMA’s own medicine finder returns no centrally authorised product, and the agency is explicit that medicines not found centrally may exist only via national registers — a check that, for Selank, also comes up empty.¹ Because it carries no marketing authorisation anywhere in the Union, there is no lawful route by which an EU physician can prescribe it as a medicine. It is not a licensed drug that happens to be hard to obtain; it is a compound that has never cleared the regulatory gate at all.

This is the gap the marketing language papers over. Selank can be extensively characterised, synthesised to high purity, and sold by reputable suppliers, and still be nowhere near being a medicine in any legal sense. Under Directive 2001/83/EC — the Community code on medicinal products for human use — no medicinal product may be placed on the EU market unless a marketing authorisation has been issued by the competent authorities.² Approval is a status a regulator confers after review, not a quality a peptide earns in a lab.

But it’s registered in Russia — doesn’t that count?

Not in Europe. Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and is registered as a drug inside Russia, where it has years of clinical use behind it.³⁴ That registration is real. It is also jurisdictionally local. A marketing authorisation granted by one country’s regulator does not transfer to another; the EU recognises medicines authorised centrally by the EMA or nationally by a member state, and a Russian registration is neither.¹² Selank sits in exactly the same regulatory position as its better-known sibling Semax: registered in Russia, unapproved anywhere in the EU or United States. Our Selank vs Semax comparison walks through how alike the two are pharmacologically; their legal status in Europe is identical too.

So why is Selank sold all over Europe?

Because there are two different markets, and only one of them is legitimate. Selank is widely supplied in much of the EU strictly as a research chemical, on a “for research use only” basis, as a reference material.¹ That is lawful in much of the bloc. What is not permitted is selling or supplying Selank for human use. Legitimate supply is RUO only; the moment a product is offered, labelled, or described for human consumption, it crosses out of research-reagent territory and into the regulated medicines regime it has never qualified for.²

Selank at a glance: the answer changes entirely depending on which question you are actually asking.

Could it be sold as a supplement instead?

No, and this is the gate most people forget exists. There is a separate route by which a substance can enter the consumer market — as a food or food supplement — and Selank has not passed it either. Synthetic peptides without a meaningful history of food consumption in the EU before May 1997 fall under the Novel Food Regulation, which requires authorisation before such an ingredient can be placed on the market as food.⁵ Selank is not on the Union list of authorised novel foods, and there is no published authorisation for it as a food ingredient.⁵ So both consumer doors — medicine and food — are closed. The only door that is open is the research-reagent one, and only on RUO terms.

Does the law say the same thing in every country?

No, and this is where confident blanket statements fail. Member states apply their own national medicines law, operating under the common EU framework of Directive 2001/83/EC.² The reason the picture is not uniform is structural: a directive is not a single rulebook applied identically across the bloc but a shared architecture that each member state transposes into its own national medicines law,² so an unapproved compound’s handling, classification, and enforcement can differ from one country to the next even though the underlying European framework is the same. Selank is not a scheduled narcotic in this picture. But that is not a clean bill of legal health: possession, use, or importation for human use can be treated differently from one jurisdiction to the next, even though the same compound circulates freely as a research reagent elsewhere.²

Selank is legal to handle as a characterised research reference material across much of the EU, and there is no lawful route to use it as a medicine anywhere in the Union. Both statements are true at once.

Zero EU member states have approved Selank as a medicine, and zero physicians can lawfully prescribe it — a Russian registration notwithstanding.

What about doping — is Selank banned in sport?

Here the honest answer is an ambiguity, not a verdict. Selank is not explicitly named on the 2026 World Anti-Doping Agency Prohibited List.⁶ That is not the same as being permitted. WADA’s catch-all S0 clause covers non-approved substances — those not approved by any governmental regulatory health authority for human therapeutic use, including drugs under pre-clinical or clinical development and discontinued or designer drugs — and the 2026 list applies that clause by example to peptides such as BPC-157.⁶ A compound that has never been approved as a medicine anywhere in the West is precisely the kind of thing S0 is written to capture. An athlete looking for a tidy “banned” or “allowed” will not find one; the realistic reading is that Selank sits in the grey zone S0 was designed to police, and should be treated as a doping risk rather than as cleared.⁶

What should an honest answer concede?

Plenty. The country-by-country variation is real, not a rhetorical hedge: an arrangement that is unremarkable in one member state may attract scrutiny in another once human use enters the frame.² The doping position is genuinely unresolved rather than settled. The Russian registration is authentic but jurisdictionally inert in Europe. And the central caveat bears repeating: none of the above should be read as a route to using Selank in or on a human being. The legality that exists is the legality of a research reagent, and it evaporates the instant the use case changes. Anyone citing a single confident legal status for Selank has skipped the only question that matters: legal for what.

This is not legal advice. It is a summary of verifiable regulatory facts from official sources, current as of writing, and medicines law differs between member states and changes over time. It remains the buyer’s responsibility to understand the rules that apply in their own jurisdiction.

Everything Condor Research supplies in this category is a characterised research reference material, sold strictly for research use only. Our Selank listing — like everything in the Selank primer — is documented by a certificate of analysis confirming identity and purity, and it is not an approved or prescribable medicine, not a food or supplement, not intended for human or veterinary use, and nothing here is a recommendation to use any compound. The distinction between a regulated, approved medicine and an RUO reference material is not a formality — it is the entire legal and scientific basis on which legitimate supply rests.

Condor Research · Scientific desk. Research use only (RUO). The compounds discussed are supplied strictly as characterised reference materials for in-vitro and laboratory research; they are not approved medicines, foods, or supplements, are not intended for human or veterinary use, and nothing in this article is medical or legal advice or a recommendation to use any compound.